SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017731
Filing Date
2024-05-03
Accepted
2024-05-03 16:42:05
Documents
14
Period of Report
2024-04-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42226
2 ex16-1.htm EX-16.1 5038
  Complete submission text file 0001493152-24-017731.txt   225516

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ser-20240429.xsd EX-101.SCH 3042
4 XBRL LABEL FILE ser-20240429_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ser-20240429_pre.xml EX-101.PRE 22378
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3802
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24913929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)